metabolism of oxycodone with the Phase I and II pathways. Additionally, it examined the result of oxycodone within the relevant CYP and UGT enzymes. Oxycodone has many favorable pharmacodynamic and pharmacokinetic properties which account for its use in managing postoperative and most cancers soreness. Having said that, its metabolism and e